{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T17:35:24Z","timestamp":1790098524189,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K11907"],"award-info":[{"award-number":["24K11907"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K08207"],"award-info":[{"award-number":["23K08207"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K08207"],"award-info":[{"award-number":["23K08207"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K11907"],"award-info":[{"award-number":["24K11907"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K11907"],"award-info":[{"award-number":["24K11907"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["24K11907"],"award-info":[{"award-number":["24K11907"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K08207"],"award-info":[{"award-number":["23K08207"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"This study was also supported by Denka Company Limited"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2025,12,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Complement factors regulate tumour immunity in the tumour microenvironment (TME). We investigated the functions of complement 5a (C5a) and its receptors, C5aR1 and C5aR2, in forming the C5a-C5aR1 and C5a-C5aR2 signaling axes in the immune TME of pancreatic ductal adenocarcinoma (PDAC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>C5a, C5aR1 and C5aR2 were assessed in cancer cell cytoplasmic (c-) and stromal (s-) expressions in resected PDAC tissues. In vitro assays were conducted to examine endogenous C5aR1 functions in PDAC cells, and orthotopic transplantation was performed in a preclinical study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In immunohistochemistry, High C5a-C5aR1 c-axis was correlated with poor prognosis and High C5a-C5aR1 s-axis was associated with a decrease in CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells and an increase in CD11b\n                      <jats:sup>+<\/jats:sup>\n                      MDSCs. C5aR1 knockdown and CCX168, the specific C5aR1 inhibitor, impaired proliferation and the activation of the PI3K\/mTOR pathway, and enhanced gemcitabine sensitivity by increasing apoptosis. The combination of CCX168 and gemcitabine\/nab-paclitaxel demonstrated a significant reduction in tumour volume. The number of CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells was significantly increased in CCX168-treated groups, whereas CCX168 treatment resulted in a decrease in MDSCs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The C5a-C5aR1 axis may exert a tumour-promoting effect on the TME in PDAC. CCX168 appears to modulate antitumour immunity, thereby warranting future complement-based immunomodulation therapies for PDAC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41416-025-03185-0","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T14:11:40Z","timestamp":1759500700000},"page":"1791-1801","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inhibition of C5a-C5aR1 axis suppresses tumour progression by enhancing antitumour immunity and chemotherapeutic effect in pancreatic ductal adenocarcinoma"],"prefix":"10.1038","volume":"133","author":[{"given":"Ryotaro","family":"Eto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6495-0422","authenticated-orcid":false,"given":"Shigetsugu","family":"Takano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daren","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsukasa","family":"Takayashiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nozomu","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"3185_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"3185_CR2","unstructured":"Foundation for Promotion of Cancer Research. Cancer Statistics in Japan. 2024. https:\/\/ganjoho.jp\/public\/qa_links\/report\/statistics\/pdf\/cancer_statistics_2024_fig_E.pdf"},{"key":"3185_CR3","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","volume":"14","author":"WH Fridman","year":"2017","unstructured":"Fridman WH, Zitvogel L, Saut\u00e8s-Fridman C, Kroemer G. The immune contexture in cancer prognosis and treatment. Nat Rev Clin Oncol. 2017;14:717\u201334.","journal-title":"Nat Rev Clin Oncol"},{"key":"3185_CR4","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41568-019-0210-0","volume":"19","author":"LT Roumenina","year":"2019","unstructured":"Roumenina LT, Daugan MV, Petitprez F, Saut\u00e8s-Fridman C, Fridman WH. Context-dependent roles of complement in cancer. Nat Rev Cancer. 2019;19:698\u2013715.","journal-title":"Nat Rev Cancer"},{"key":"3185_CR5","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fimmu.2015.00257","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle NS, Noe R, Halbwachs-Mecarelli L, Fremeaux-Bacchi V, Roumenina LT. Complement system part II: role in immunity. Front Immunol. 2015;6:257.","journal-title":"Front Immunol"},{"key":"3185_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215900","volume":"549","author":"Y Senent","year":"2022","unstructured":"Senent Y, Tavira B, Pio R, Ajona D. The complement system as a regulator of tumor-promoting activities mediated by myeloid-derived suppressor cells. Cancer Lett. 2022;549:215900.","journal-title":"Cancer Lett"},{"key":"3185_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202350820","volume":"54","author":"NS Merle","year":"2024","unstructured":"Merle NS, Roumenina LT. The complement system as a target in cancer immunotherapy. Eur J Immunol. 2024;54:e2350820.","journal-title":"Eur J Immunol"},{"key":"3185_CR8","doi-asserted-by":"crossref","unstructured":"Revel M, Daugan MV, Saut\u00e9s-Fridman C, Fridman WH, Roumenina LT. Complement system: promoter or suppressor of cancer progression? Antibodies. 2020;9:57.","DOI":"10.3390\/antib9040057"},{"key":"3185_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13046-021-02019-0","volume":"40","author":"K Sasaki","year":"2021","unstructured":"Sasaki K, Takano S, Tomizawa S, Miyahara Y, Furukawa K, Takayashiki T, et al. C4b-binding protein \u03b1-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer. J Exp Clin Cancer Res. 2021;40:212.","journal-title":"J Exp Clin Cancer Res"},{"key":"3185_CR10","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/bjc.2016.295","volume":"115","author":"K Sogawa","year":"2016","unstructured":"Sogawa K, Takano S, Iida F, Satoh M, Tsuchida S, Kawashima Y, et al. Identification of a novel serum biomarker for pancreatic cancer, C4b-binding protein \u03b1-chain (C4BPA) by quantitative proteomic analysis using tandem mass tags. Br J Cancer. 2016;115:949\u201356.","journal-title":"Br J Cancer"},{"key":"3185_CR11","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1007\/s13402-021-00614-z","volume":"44","author":"R Shimazaki","year":"2021","unstructured":"Shimazaki R, Takano S, Satoh M, Takada M, Miyahara Y, Sasaki K, et al. Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. Cell Oncol. 2021;44:937\u201350.","journal-title":"Cell Oncol"},{"key":"3185_CR12","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1101\/gad.263327.115","volume":"30","author":"S Takano","year":"2016","unstructured":"Takano S, Reichert M, Bakir B, Das KK, Nishida T, Miyazaki M, et al. Prrx1 isoform switching regulates pancreatic cancer invasion and metastatic colonization. Genes Dev. 2016;30:233\u201347.","journal-title":"Genes Dev"},{"key":"3185_CR13","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1158\/0008-5472.CAN-12-3180","volume":"73","author":"S Kozono","year":"2013","unstructured":"Kozono S, Ohuchida K, Eguchi D, Ikenaga N, Fujiwara K, Cui L, et al. Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells. Cancer Res. 2013;73:2345\u201356.","journal-title":"Cancer Res"},{"key":"3185_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrneph.2017.69","volume":"13","author":"R Kettritz","year":"2017","unstructured":"Kettritz R. Vasculitis: A CLEAR argument for targeting complement in ANCA vasculitis. Nat Rev Nephrol. 2017;13:448\u201350.","journal-title":"Nat Rev Nephrol"},{"issue":"9","key":"3185_CR15","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1681\/ASN.2016111179","volume":"28","author":"DRW Jayne","year":"2017","unstructured":"Jayne DRW, Bruchfeld AN, Harper L, Schaier M, Venning MC, Hamilton P, et al. Randomized trial of C5a receptor inhibitor avacopan in ANCA-associated vasculitis. J Am Soc Nephrol. 2017;28(9):2756\u201367.","journal-title":"J Am Soc Nephrol"},{"key":"3185_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1056\/NEJMoa2023386","volume":"384","author":"DRW Jayne","year":"2021","unstructured":"Jayne DRW, Merkel PA, Schall TJ, Bekker P. Avacopan for the treatment of ANCA-associated vasculitis. N Engl J Med. 2021;384:599\u2013609.","journal-title":"N Engl J Med"},{"key":"3185_CR17","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1046\/j.1523-1755.2002.00139.x","volume":"61","author":"MC Perianayagam","year":"2002","unstructured":"Perianayagam MC, Balakrishnan VS, King AJ, Pereira BJ, Jaber BL. C5a delays apoptosis of human neutrophils by a phosphatidylinositol 3-kinase-signaling pathway. Kidney Int. 2002;61:456\u201363.","journal-title":"Kidney Int"},{"key":"3185_CR18","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.intimp.2004.05.017","volume":"4","author":"WF Chiou","year":"2004","unstructured":"Chiou WF, Tsai HR, Yang LM, Tsai WJ. C5a differentially stimulates the ERK1\/2 and p38 MAPK phosphorylation through independent signaling pathways to induced chemotactic migration in RAW264.7 macrophages. Int Immunopharmacol. 2004;4:1329\u201341.","journal-title":"Int Immunopharmacol"},{"key":"3185_CR19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.canlet.2017.10.003","volume":"412","author":"J Chen","year":"2018","unstructured":"Chen J, Li GQ, Zhang L, Tang M, Cao X, Xu GL, et al. Complement C5a\/C5aR pathway potentiates the pathogenesis of gastric cancer by down-regulating p21 expression. Cancer Lett. 2018;412:30\u20136.","journal-title":"Cancer Lett"},{"key":"3185_CR20","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1016\/j.jss.2012.05.065","volume":"178","author":"S Kagawa","year":"2012","unstructured":"Kagawa S, Takano S, Yoshitomi H, Kimura F, Satoh M, Shimizu H, et al. Akt\/mTOR signaling pathway is crucial for gemcitabine resistance induced by Annexin II in pancreatic cancer cells. J Surg Res. 2012;178:758\u201367.","journal-title":"J Surg Res"},{"key":"3185_CR21","doi-asserted-by":"crossref","unstructured":"Crake R, Gasmi I, Dehaye J, Lardinois F, Peiffer R, Maloujahmoum N, et al. Resistance to gemcitabine in pancreatic cancer is connected to methylglyoxal stress and heat shock response. Cells. 2023;12:1414.","DOI":"10.3390\/cells12101414"},{"key":"3185_CR22","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fimmu.2015.00262","volume":"6","author":"NS Merle","year":"2015","unstructured":"Merle NS, Church SE, Fremeaux-Bacchi V, Roumenina LT. Complement system part I - molecular mechanisms of activation and regulation. Front Immunol. 2015;6:262.","journal-title":"Front Immunol"},{"key":"3185_CR23","doi-asserted-by":"crossref","unstructured":"Beach C, MacLean D, Majorova D, Melemenidis S, Nambiar DK, Kim RK, et al. Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1. J Clin Invest. 2024;134:e168277.","DOI":"10.1172\/JCI185067"},{"key":"3185_CR24","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ymthe.2023.12.010","volume":"32","author":"X Luan","year":"2024","unstructured":"Luan X, Lei T, Fang J, Liu X, Fu H, Li Y, et al. Blockade of C5a receptor unleashes tumor-associated macrophage antitumor response and enhances CXCL9-dependent CD8(+) T cell activity. Mol Ther. 2024;32:469\u201389.","journal-title":"Mol Ther"},{"key":"3185_CR25","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.canlet.2021.12.027","volume":"529","author":"S Ortiz-Espinosa","year":"2022","unstructured":"Ortiz-Espinosa S, Morales X, Senent Y, Alignani D, Tavira B, Macaya I, et al. Complement C5a induces the formation of neutrophil extracellular traps by myeloid-derived suppressor cells to promote metastasis. Cancer Lett. 2022;529:70\u201384.","journal-title":"Cancer Lett"},{"key":"3185_CR26","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1158\/2159-8290.CD-16-1184","volume":"7","author":"D Ajona","year":"2017","unstructured":"Ajona D, Ortiz-Espinosa S, Moreno H, Lozano T, Pajares MJ, Agorreta J, et al. A combined PD-1\/C5a blockade synergistically protects against lung cancer growth and metastasis. Cancer Discov. 2017;7:694\u2013703.","journal-title":"Cancer Discov"},{"key":"3185_CR27","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1016\/j.biopha.2018.04.057","volume":"103","author":"XY Zhang","year":"2018","unstructured":"Zhang XY, Liu Y, He T, Yang TT, Wu J, Cianflone K, et al. Anaphylatoxin C5a induces inflammation and reduces insulin sensitivity by activating TLR4\/NF-kB\/PI3K signaling pathway in 3T3-L1 adipocytes. Biomed Pharmacother. 2018;103:955\u201364.","journal-title":"Biomed Pharmacother"},{"key":"3185_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1239146","volume":"14","author":"J Santos-L\u00f3pez","year":"2023","unstructured":"Santos-L\u00f3pez J, de la Paz K, Fern\u00e1ndez FJ, Vega MC. Structural biology of complement receptors. Front Immunol. 2023;14:1239146.","journal-title":"Front Immunol"},{"key":"3185_CR29","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41577-023-00926-1","volume":"24","author":"DC Mastellos","year":"2024","unstructured":"Mastellos DC, Hajishengallis G, Lambris JD. A guide to complement biology, pathology and therapeutic opportunity. Nat Rev Immunol. 2024;24:118\u201341.","journal-title":"Nat Rev Immunol"},{"key":"3185_CR30","doi-asserted-by":"publisher","first-page":"11060","DOI":"10.1096\/fj.201800980RR","volume":"33","author":"JA Nabizadeh","year":"2019","unstructured":"Nabizadeh JA, Manthey HD, Panagides N, Steyn FJ, Lee JD, Li XX, et al. C5a receptors C5aR1 and C5aR2 mediate opposing pathologies in a mouse model of melanoma. FASEB J. 2019;33:11060\u201371.","journal-title":"FASEB J"},{"key":"3185_CR31","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/ni.1655","volume":"9","author":"MM Markiewski","year":"2008","unstructured":"Markiewski MM, DeAngelis RA, Benencia F, Ricklin-Lichtsteiner SK, Koutoulaki A, Gerard C, et al. Modulation of the antitumor immune response by complement. Nat Immunol. 2008;9:1225\u201335.","journal-title":"Nat Immunol"},{"key":"3185_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-58910-3","volume":"16","author":"Z Pan","year":"2025","unstructured":"Pan Z, Tan Z, Xu N, Yao Z, Zheng C, Shang J, et al. Integrative proteogenomic characterization reveals therapeutic targets in poorly differentiated and anaplastic thyroid cancers. Nat Commun. 2025;16:3601.","journal-title":"Nat Commun"},{"key":"3185_CR33","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.7150\/ijbs.70013","volume":"18","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang Q, Wu M, Zhang P, Huang L, Ai X, et al. Suppressing MDSC infiltration in tumor microenvironment serves as an option for treating ovarian cancer metastasis. Int J Biol Sci. 2022;18:3697\u2013713.","journal-title":"Int J Biol Sci"},{"key":"3185_CR34","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1158\/2326-6066.CIR-24-0250","volume":"13","author":"Y Senent","year":"2025","unstructured":"Senent Y, Rem\u00edrez A, Rep\u00e1raz D, Llopiz D, Celias DP, Sainz C, et al. The C5a\/C5aR1 axis promotes migration of tolerogenic dendritic cells to lymph nodes, impairing the anticancer immune response. Cancer Immunol Res. 2025;13:384\u201399.","journal-title":"Cancer Immunol Res"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03185-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03185-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03185-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T22:02:07Z","timestamp":1765317727000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-025-03185-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,28]]}},"alternative-id":["3185"],"URL":"https:\/\/doi.org\/10.1038\/s41416-025-03185-0","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"1 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"ST and MO report receiving grants for this study from Denka Co., Ltd. No potential conflicts of interest were disclosed by the other authors.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research was carried out according to the World Medical Association Declaration of Helsinki. The study protocol (protocol #2958) was approved by the ethics committees of Chiba University and written informed consent was obtained from each patient before surgery. The animal procedures (#A5-090) were approved by the Institutional Animal Care and Use Committee of Chiba University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors consented to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication"}}]}}